IQVIA Holdings Inc
IQVIA Holdings Inc (IQV) Implied Volatility Current
IQV implied volatility is 35%. IV Rank is 30%, placing current premiums in the bottom of their 52-week range.
Read more
Tracking IQV implied volatility helps you identify when options premiums on IQVIA Holdings Inc are historically cheap or expensive, and where the best trades are hiding. IQVIA Holdings Inc implied volatility reflects the market's expectation of future price movement: when IQV IV rises, option premiums increase, creating opportunities for sellers, and when it drops, buyers can find cheaper contracts. Use our scanner to monitor IQVIA Holdings Inc's implied volatility current levels in real time and filter for high-probability trades.
Implied volatility is derived from option prices using models like Black-Scholes and represents the annualized expected move of an underlying stock. For IQV, tracking metrics like IQV IV rank helps traders understand whether current implied volatility is historically high or low. IV rank compares today's reading against the past year's range — a high rank on IQV signals rich premiums and potential mean-reversion, while a low rank may favor long options strategies.
IQVIA Holdings Inc. provides advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment offers a range of cloud-based applications and related implementation services; real world solutions that enable life sciences and provider customers to generate and disseminate evidence, which informs health care decision making and improves patients' outcomes; and strategic and implementation consulting services, such as advanced analytics and commercial processes outsourcing services.
This segment also provides country level performance metrics related to sales of pharmaceutical products, prescribing trends, medical treatment, and promotional activity across various channels, including retail, hospital, and mail order; and measurement of sales or prescribing activity at the regional, zip code, and individual prescriber level. The Research & Development Solutions segment offers project management and clinical monitoring; clinical trial support; virtual trials; and strategic planning and design services, as well as central laboratory, genomic, bioanalytical, ADME, discovery, and vaccine and biomarker laboratory services. The Contract Sales & Medical Solutions segment provides health care provider and patient engagement services, and scientific strategy and medical affairs services. It serves pharmaceutical, biotechnology, device and diagnostic, and consumer health companies. The company has a strategic collaboration with HealthCore, Inc. The company was formerly known as Quintiles IMS Holdings, Inc. and changed its name to IQVIA Holdings Inc. in November 2017. IQVIA Holdings Inc. was founded in 1982 and is headquartered in Durham, North Carolina.
Premium sellers, directional traders, and spread builders all need the same starting point: a clear read on where IQV implied volatility sits today versus where it has been. Our scanner ranks IQVIA Holdings Inc implied volatility against its historical range, surfaces extremes in IQV IV rank, and pairs every reading with the trades that exploit it. Stop guessing whether IQVIA Holdings Inc IV is rich or cheap — measure it, then act on it.
Implied Volatility
IV is below its typical range - premiums look reasonable for buyers.
As of September 16, 2026
Trade options with IV on your side
Track IQV IV rank across every expiration, spot where volatility is elevated, and identify high-probability setups before the window closes.
Start your 14-day free trial→